The following government grants in the FederalGrants.com database contain the term housing in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Employer Engagement Program |
93.576 |
HHS-2022-ACF-ORR-ZN-0072 |
| Secondary Analyses of Child Care and Early Education Data |
93.575 |
HHS-2022-ACF-OPRE-YE-0057 |
| Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) |
93.393, 93.396, 93.399 |
PAR-21-331 |
| Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed) |
93.393, 93.396, 93.399 |
PAR-21-332 |
| GPD Capital Grant |
64.024 |
VA-GPD-CG-FY2022 |
| Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) |
93.279 |
PAR-22-027 |
| Basic Research in Cancer Health Disparities (R03 Clinical Trial Not Allowed) |
93.393 |
PAR-21-324 |
| NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genetic Research Centers (GRCs) (U01 Clinical Trial Optional) |
93.847 |
RFA-DK-21-022 |
| Ethnic Community Self-Help Program |
93.576 |
HHS-2022-ACF-ORR-RE-0048 |
| Collaborative Partnership between Research Centers in Minority Institutions (RCMI) and Alcohol Research Centers (U54 Clinical Trial Optional) |
93.273 |
RFA-AA-21-015 |
| Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) |
93.393 |
PAR-21-323 |
| Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) |
93.393 |
PAR-21-322 |
| NINDS Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD) Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) |
93.853 |
PAR-22-022 |
| Longitudinal Single Cell Characterization of ADRD Postmortem Tissue (R01 Clinical Trial Not Allowed) |
93.853, 93.866 |
PAR-22-029 |
| Data, Evaluation and Coordinating Center for: A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT) (U24 Clinical Trial Not Allowed) |
93.353, 93.393, 93.394, 93.395, 93.396, 93.397 |
RFA-CA-21-058 |
| NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed) |
93.279 |
PAR-21-320 |
| NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) |
93.121 |
PAR-21-317 |
| HEAL Initiative: Interdisciplinary Teams to Elucidate the Mechanisms of Device-Based Pain Relief (RM1 Clinical Trial Optional) |
93.121, 93.213, 93.350, 93.853 |
RFA-NS-22-016 |
| A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT U01 Clinical Trial Not Allowed) |
93.395 |
RFA-CA-21-057 |
| National Cancer Institute Youth Enjoy Science Research Education Program (R25 Clinical Trial Not Allowed) |
93.398 |
RFA-CA-21-020 |
| Translational and Basic Science Research in Early Lesions (TBEL) (U54 Clinical Trial Not Allowed) |
93.394, 93.396 |
RFA-CA-21-054 |
| Translational and Basic Science Research in Early Lesions (TBEL) Coordinating and Data Management Center (U24 Clinical Trial Not Allowed) |
93.394, 93.396 |
RFA-CA-21-055 |
| Basic Center Program |
93.623 |
HHS-2022-ACF-ACYF-CY-0069 |
| FY2022 Title V Competitive Sexual Risk Avoidance Education |
93.787 |
HHS-2022-ACF-ACYF-TS-0055 |
| Pediatric Centers of Excellence in Nephrology (P50 Clinical Trial Optional) |
93.847 |
RFA-DK-21-024 |
| Multipurpose Prevention Technology: Novel Systemic Options for Young Adults (R43/R44 Clinical Trial Not Allowed) |
93.242, 93.855, 93.865 |
PAR-21-297 |
| NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required) |
93.398 |
PAR-21-296 |
| NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed) |
93.398 |
PAR-21-295 |
| Limited Competition: Knockout Mouse Production and Phenotyping Project (UM1) Clinical Trial Not Allowed |
93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.273, 93.279, 93.313, 93.351, 93.396, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.865, 93.866, 93.867 |
RFA-HG-21-036 |
| Limited Competition: Knockout Mouse Phenotyping Project Data Coordination Center and Database (UM1 Clinical Trial Not Allowed) |
93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.273, 93.279, 93.313, 93.351, 93.396, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.865, 93.866, 93.867 |
RFA-HG-21-037 |
| Transitional Living Program |
93.550 |
HHS-2022-ACF-ACYF-CX-0061 |
| National Program for the Career Development Of Physician Scientists in Diabetes Research (Diabetes - Docs) (K12 Clinical Trial Optional) |
93.847 |
RFA-DK-21-019 |
| Street Outreach Program |
93.557 |
HHS-2022-ACF-ACYF-YO-0062 |
| Maternity Group Home Program |
93.550 |
HHS-2022-ACF-ACYF-YZ-0063 |
| Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed) |
93.398 |
PAR-21-279 |
| Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) |
93.398 |
PAR-21-278 |
| Service Area Competition-Additional Areas: Colebrook, NH and San Juan, PR |
93.224 |
HRSA-22-106 |
| Learning Disabilities Innovation Hubs (P20 Clinical Trial Optional) |
93.865 |
RFA-HD-22-005 |
| Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional) |
93.394, 93.395, 93.399 |
RFA-CA-21-056 |
| Impact of Technology and Digital Media (TDM) Exposure/Usage on Child and Adolescent Development (P01 Clinical Trial Optional) |
93.865 |
RFA-HD-22-009 |
Search Results 3201-3240 of 17970
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 [Next] |
